Compounds > beta-naphthoflavone

beta-naphthoflavone and Benign Neoplasms

beta-naphthoflavone has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Chatuphonprasert, W; Jarukamjorn, K; Putalun, W1

Reviews

1 review(s) available for beta-naphthoflavone and Benign Neoplasms

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

1 other study(ies) available for beta-naphthoflavone and Benign Neoplasms

ArticleYear
Regulation of cancer-related genes - Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in β-naphthoflavone-treated mice by miroestrol.
    The Journal of pharmacy and pharmacology, 2016, Volume: 68, Issue:4

    Topics: Animals; beta-Naphthoflavone; Catechol O-Methyltransferase; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P450 Family 19; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Liver; Mice, Inbred ICR; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Phytoestrogens; Steroids; Uterus

2016